Reactivation of murine tumour-infiltrating lymphocytes with solid-phase anti-CD3 antibody: in vitro cytokine production is associated with in vivo efficacy
- 30 April 1994
- journal article
- Published by Elsevier in Surgical Oncology
- Vol. 3 (2) , 79-89
- https://doi.org/10.1016/0960-7404(94)90003-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma.The Journal of Experimental Medicine, 1993
- A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.The Journal of Experimental Medicine, 1992
- Activation by anti-CD3 of tumor-draining lymph node cells for specific adoptive immunotherapyCellular Immunology, 1991
- Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysisInternational Immunology, 1990
- Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humansCancer Immunology, Immunotherapy, 1989
- TUMOUR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN TREATMENT OF ADVANCED CANCERThe Lancet, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Functional characterization of T lymphocytes propagated from human lung carcinomasClinical Immunology and Immunopathology, 1986
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984